Odonate Therapeutics, Inc.

Odonate Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in San Diego, California and currently employs 137 full-time employees. The company went IPO on 2017-12-07. Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The firm is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The firm is no longer in development of tesetax.

Peers: 9 METERS BIOPHARMA, INC. Aquestive Therapeutics Inc Clearside Biomedical, Inc Enliven Therapeutics Inc Johnson & Johnson OPIANT PHARMACEUTICALS, INC. Longboard Pharmaceuticals, Inc. Medicine Man Technologies, Inc. Mystic Holdings Inc./NV

Dive deeper

Financial snapshot data is not available right now.

Stock Price

Market Cap: $49.87 Million